Download | < Back |
18 Nov 2021 | |
Cadila Healthcare Ltd has informed BSE regarding a Press Release dated November 18, 2021 titled "Zydus Cadila gets 180-day exclusivity for Nelarabine injection, announces final approval from USFDA". | |
View all announcements for CADILA HEALTHCARE LTD. | Source: BSE India |